{"id":"https://openalex.org/W3013968074","doi":"https://doi.org/10.1182/bloodadvances.2019001256","title":"Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma","display_name":"Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma","publication_year":2020,"publication_date":"2020-03-31","ids":{"openalex":"https://openalex.org/W3013968074","doi":"https://doi.org/10.1182/bloodadvances.2019001256","mag":"3013968074","pmid":"https://pubmed.ncbi.nlm.nih.gov/32232478","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7160286"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2019001256","doi":"https://doi.org/10.1182/bloodadvances.2019001256","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2019001256","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/4/7/1265/1722814/advancesadv2019001256.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ashpublications.org/bloodadvances/article-pdf/4/7/1265/1722814/advancesadv2019001256.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076948857","display_name":"Yana Pikman","orcid":"https://orcid.org/0000-0002-5336-0216","observed_orcids":["https://orcid.org/0000-0002-5336-0216"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yana Pikman","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","Division of Hematology/Oncology and"],"raw_orcid":"https://orcid.org/0000-0002-5336-0216","affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Division of Hematology/Oncology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102795509","display_name":"Amy Saur Conway","orcid":"https://orcid.org/0000-0003-4583-5127","observed_orcids":["https://orcid.org/0000-0003-4583-5127"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Saur Conway","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048549389","display_name":"Amanda L. Robichaud","orcid":"https://orcid.org/0000-0003-1302-4135","observed_orcids":["https://orcid.org/0000-0003-1302-4135"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda L. Robichaud","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018167603","display_name":"Samuel Kitara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel Kitara","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046068707","display_name":"Alanna J. Church","orcid":"https://orcid.org/0000-0002-4835-5770","observed_orcids":["https://orcid.org/0000-0002-4835-5770"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alanna J. Church","raw_affiliation_strings":["Department of Pathology, Boston Children\u2019s Hospital, Boston, MA;"],"raw_orcid":"https://orcid.org/0000-0002-4835-5770","affiliations":[{"raw_affiliation_string":"Department of Pathology, Boston Children\u2019s Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001300219","display_name":"Alyssa L. Kennedy","orcid":"https://orcid.org/0000-0001-7948-5933","observed_orcids":["https://orcid.org/0000-0001-7948-5933"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alyssa L. Kennedy","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","Division of Hematology/Oncology and"],"raw_orcid":"https://orcid.org/0000-0001-7948-5933","affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Division of Hematology/Oncology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048748466","display_name":"Lewis B. Silverman","orcid":"https://orcid.org/0009-0007-7275-7650","observed_orcids":["https://orcid.org/0009-0007-7275-7650"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lewis B. Silverman","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","Division of Hematology/Oncology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Division of Hematology/Oncology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023365950","display_name":"Amy Louise Billett","orcid":"https://orcid.org/0000-0002-6005-054X","observed_orcids":["https://orcid.org/0000-0002-6005-054X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy L. Billett","raw_affiliation_strings":["Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","Division of Hematology/Oncology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Division of Hematology/Oncology and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026688095","display_name":"David M. Weinstock","orcid":"https://orcid.org/0000-0002-8724-3907","observed_orcids":["https://orcid.org/0000-0002-8724-3907"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M. Weinstock","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and"],"raw_orcid":"https://orcid.org/0000-0002-8724-3907","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042483676","display_name":"Marian H. Harris","orcid":"https://orcid.org/0000-0002-9956-664X","observed_orcids":["https://orcid.org/0000-0002-9956-664X"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marian H. Harris","raw_affiliation_strings":["Department of Pathology, Boston Children\u2019s Hospital, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Boston Children\u2019s Hospital, Boston, MA;","institution_ids":["https://openalex.org/I1288882113"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011985711","display_name":"Kimberly Stegmaier","orcid":"https://orcid.org/0000-0003-0218-7895","observed_orcids":["https://orcid.org/0000-0003-0218-7895"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kimberly Stegmaier","raw_affiliation_strings":["Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA","Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","Division of Hematology/Oncology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA","institution_ids":["https://openalex.org/I107606265","https://openalex.org/I136199984","https://openalex.org/I63966007"]},{"raw_affiliation_string":"Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Division of Hematology/Oncology and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5011985711"],"corresponding_institution_ids":["https://openalex.org/I107606265","https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I63966007"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":{"value":3800,"currency":"USD","value_usd":3800},"fwci":0.657,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.66508903,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"4","issue":"7","first_page":"1265","last_page":"1269"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9682999849319458,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11811","display_name":"Cutaneous lymphoproliferative disorders research","score":0.009800000116229057,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatosplenic-t-cell-lymphoma","display_name":"hepatosplenic T-cell lymphoma","score":0.9929999709129333},{"id":"https://openalex.org/keywords/ezh2","display_name":"EZH2","score":0.9440000057220459},{"id":"https://openalex.org/keywords/ezh2-inhibitors","display_name":"EZH2 inhibitors","score":0.9179999828338623},{"id":"https://openalex.org/keywords/ezh2-mutation","display_name":"EZH2 mutation","score":0.9629999995231628},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.953000009059906},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6050000190734863},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.5189999938011169}],"concepts":[{"id":"https://openalex.org/C50171091","wikidata":"https://www.wikidata.org/wiki/Q17917770","display_name":"EZH2","level":4,"score":0.8687542676925659},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.6024689078330994},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5286130309104919},{"id":"https://openalex.org/C111936080","wikidata":"https://www.wikidata.org/wiki/Q913367","display_name":"Enhancer","level":4,"score":0.48777633905410767},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41482314467430115},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32849663496017456},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2791339159011841},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23531374335289001},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.09872612357139587},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0912255048751831},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016399","descriptor_name":"Lymphoma, T-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016692","descriptor_name":"Receptors, Antigen, T-Cell, gamma-delta","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/bloodadvances.2019001256","doi":"https://doi.org/10.1182/bloodadvances.2019001256","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2019001256","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/4/7/1265/1722814/advancesadv2019001256.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7160286","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7160286","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:32232478","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32232478","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2019001256","doi":"https://doi.org/10.1182/bloodadvances.2019001256","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2019001256","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/4/7/1265/1722814/advancesadv2019001256.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.5199999809265137}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[{"id":"https://openalex.org/G5290565452","display_name":"Targeting mitochondrial one carbon folate metabolism for novel T-cell acute lymphoblastic leukemia therapy","funder_award_id":"K08CA222684","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6342997465","display_name":null,"funder_award_id":"CA210030","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7934329832","display_name":"Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer","funder_award_id":"R35CA210030","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320308906","display_name":"St. Baldrick's Foundation","ror":"https://ror.org/03h1gea69"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3013968074.pdf","grobid_xml":"https://content.openalex.org/works/W3013968074.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1971313898","https://openalex.org/W1992915563","https://openalex.org/W2003262666","https://openalex.org/W2017492512","https://openalex.org/W2024373518","https://openalex.org/W2061846271","https://openalex.org/W2068478831","https://openalex.org/W2071080254","https://openalex.org/W2100630390","https://openalex.org/W2151853252","https://openalex.org/W2439825102","https://openalex.org/W2566669267","https://openalex.org/W2583051589","https://openalex.org/W2747620054","https://openalex.org/W2790566984","https://openalex.org/W2797292560","https://openalex.org/W2804974301"],"related_works":["https://openalex.org/W2103210803","https://openalex.org/W4237549610","https://openalex.org/W4284991400","https://openalex.org/W3032450341","https://openalex.org/W2521966611","https://openalex.org/W2790566984","https://openalex.org/W2988353192","https://openalex.org/W3132733625","https://openalex.org/W2981601309","https://openalex.org/W2887768610"],"abstract_inverted_index":{"Key":[0],"Points":[1],"We":[2],"report":[3],"a":[4],"patient":[5],"with":[6],"hepatosplenic":[7],"T-cell":[8],"lymphoma":[9],"(HSTL)":[10],"and":[11],"compare":[12],"the":[13,16],"disease":[14],"to":[15,36],"derived":[17],"xenograft":[18,33],"model.":[19],"Enhancer":[20],"of":[21,28],"zeste":[22],"homolog":[23],"2":[24],"(EZH2)":[25],"inhibitor":[26],"treatment":[27],"an":[29],"EZH2-mutant":[30],"HSTL":[31],"patient-derived":[32],"model":[34],"led":[35],"prolonged":[37],"survival.":[38]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-04-03T00:00:00"}